FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
| Brand name | AIRDUO DIGIHALER |
|---|---|
| Active ingredient | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE |
| Strength | 0.232MG/INH;EQ 0.014MG BASE/INH |
| Dosage form | POWDER |
| Route | INHALATION |
| Modality | Small molecule |
| FDA approval | July 2019 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 11173259*PED | January 2041 | — |
| 11173259 | July 2040 | product |
| 11344685*PED | March 2040 | — |
| 11969544*PED | February 2040 | — |
| 11344685 | September 2039 | product |
| 11969544 | August 2039 | product |
| 10918816*PED | June 2036 | — |
| 10918816 | December 2035 | product |
| 9066957*PED | April 2035 | — |
| 9066957 | October 2034 | product |
| 10195375*PED | August 2031 | — |
| 10195375 | February 2031 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.